Publications
| Title | Publication Date | Price |
|---|---|---|
Partnering and M&A YearbookYearbook 2012 Provides comprehensive understanding and unprecedented access to the partnering and M&A deals and agreements entered into by the worlds leading healthcare companies during 2011. | January 2012 | £1,910 |
Orphan Drug Markets in EuropeKey developments and the strategies of major pharmaceutical companies A comprehensive overview of orphan drugs in Europe and future opportunities. | November 2011 | £1,495 |
Vaccine Partnering Terms and AgreementsProvides detailed understanding and analysis of how and why companies enter vaccine partnering deals, plus access to actual vaccine agreements Provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. | November 2011 | £1,734 |
Bioinformatics Partnering Terms and AgreementsProvides comprehensive insight into bioinformatics partnering deals and agreements entered into by leading healthcare companies. | November 2011 | £1,708 |
Healthcare & Pharmaceuticals in Latin AmericaA guide to the markets and regulations A comprehensive overview of the healthcare market in Latin America including Argentina - Belize – Bolivia – Brazil – Chile – Colombia - Costa Rica - Costa Rica – Ecuador - El Salvador – Guatemala – Honduras - Mexico - Nicaragua – Panama – Paraguay – Peru – Uruguay – Venezuela | September 2011 | £995 |
Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018Future Therapies for Birth Control and Reproductive Health Provides analysis of over ten key marketed products and indentifies over 40 R&D candidates in preclinical to clinical stages of development. | May 2011 | £1,795 |
The Global Cancer Vaccine MarketPipeline Analysis and Future Market Impact (2nd Ed) Covers key therapeutic cancer vaccine candidates in late-phase development based on sales forecasts to 2020 | January 2011 | £1,700 |
Pharmaceutical Market Trends, 2010 - 2014Key market forecasts & growth opportunities (4th Edition) 4th Edition report provides an excellent overview and analysis of the global pharmaceutical market to the end of 2009 with forecasts until 2014 | October 2010 | £1,495 |
The Global Pain Therapeutics Market4th Edition: Market Trends & R&D Insights | September 2010 | £1,085 |
Traumatic Brain InjuryR&D Pipeline Assessment and Market Prospects | August 2010 | £805 |